Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Its NHS access (under NICE TA1026) is based on weight management criteria: BMI 35 or above with at least one weight-related comorbidity, accessed through specialist NHS weight management services
IL-6: More specific to the inflammatory pathways tirzepatide targets
Out-of-pocket costs vary by insurance and dose
This messaging can make it seem like youre getting the same benefits as FDA-approved GLP-1s like Wegovy (semaglutide) or Zepbound (tirzepatide), but the marketing is extremely misleading
The before-and-after photos are dramatic
.png)
US$ 20.80
.png)
US$ 27.58
US$ 28.68
